scispace - formally typeset
P

Paulo Loureiro de Sousa

Researcher at University of Strasbourg

Publications -  68
Citations -  3534

Paulo Loureiro de Sousa is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Dementia with Lewy bodies & Thought disorder. The author has an hindex of 22, co-authored 62 publications receiving 2518 citations. Previous affiliations of Paulo Loureiro de Sousa include University of Liverpool & Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

Non-invasive assessment of skeletal muscle fibrosis in mice using nuclear magnetic resonance imaging and ultrasound shear wave elastography.

TL;DR: In this paper, a mouse model with variable levels of induced skeletal muscle fibrosis displaying minimal inflammation and no fat infiltration was described, and how fibrosis affects non-invasive metrics derived from nuclear magnetic resonance (NMR) and ultrasound shear-wave elastography (SWE) associated with a passive biomechanical assay.
Posted ContentDOI

Multi-influential interactions alters behaviour and cognition through six main biological cascades in Down syndrome mouse models

TL;DR: Taking advantage of DS mouse models, behavior and cognition, brain morphology and hippocampal gene expression are investigated in a controlled environment and it is unraveled how multiple genetic interactions between different regions of the chromosome 21 contribute in altering the outcome of the behavioural, morphological and molecular/pathways phenotypes.
Journal ArticleDOI

Multi-parametric quantitative MRI reveals three different white matter subtypes.

TL;DR: In this paper, the authors used quantitative multi-parametric MRI to evaluate in what respect these inhomogeneities could correspond to brain white matter subtypes with specific characteristics and spatial distribution.

neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies

TL;DR: The new Dmdmdx/Largemyd mouse model is viable and shows a severe phenotype that is associated with the lack of dystrophin in muscle, and has proven to be very useful for the study of several other therapies, because injected cells can be screened both through DNA and protein analysis.